Do you know what Annex XIV of REACH is and how to apply for an authorization?<\/p>\r\n\r\n\r\n\r\n
One of the key mechanisms of the REACH Regulation<\/a> is Annex XIV,<\/strong> which includes substances that, due to the risks associated with their use, require prior<\/strong> authorisation<\/strong> to continue being used or placed on the market.<\/p>\r\n\r\n\r\n\r\n These restrictions not only aim to protect human health and the environment, but also promote the substitution of hazardous substances with safer and more sustainable alternatives.<\/strong><\/p>\r\n\r\n\r\n\r\n Annex XIV<\/a>, also known as the Authorisation List<\/strong>, contains certain Substances of Very High Concern (SVHCs) <\/strong>that were previously included in the Candidate List.<\/a><\/p>\r\n\r\n\r\n\r\n ECHA periodically reviews the Candidate List to identify substances that should be prioritised for inclusion in Annex XIV, based on criteria such as:<\/p>\r\n\r\n\r\n\r\n Once a substance is included in Annex XIV, it may no longer be used or placed on the market without an explicit authorisation granted by the European Commission.<\/strong><\/p>\r\n\r\n\r\n\r\n If your company wants to continue using a substance listed in Annex XIV, it must obtain an authorisation for that specific use.<\/strong><\/p>\r\n\r\n\r\n\r\n Since this is a lengthy and costly process, it’s essential to define a suitable strategy before starting the application work:<\/p>\r\n\r\n\r\n\r\n Using an Annex XIV substance without an authorisation can lead to penalties, trade restrictions, and even withdrawal of products from the market.<\/strong><\/p>\r\n\r\n\r\n\r\n Each substance included in Annex XIV is assigned two key dates:<\/p>\r\n\r\n\r\n\r\n If the application is submitted after the latest application date, the company must stop<\/strong> using the substance once the sunset date is reached, and may only resume its use if the authorisation is granted.<\/p>\r\n\r\n\r\n\r\n The applicant company must submit a dossier that contains:<\/p>\r\n\r\n\r\n\r\nWhich substances are included in Annex XIV?<\/strong><\/h2>\r\n\r\n\r\n\r\n
\r\n
My company uses a substance subject to authorisation \u2013 what should I do?<\/strong><\/h2>\r\n\r\n\r\n\r\n
\r\n
What if I don\u2019t have an authorisation?<\/strong><\/h2>\r\n\r\n\r\n\r\n
When must an authorisation be requested?<\/strong><\/h2>\r\n\r\n\r\n\r\n
\r\n
What information must an authorisation application include?<\/strong><\/h2>\r\n\r\n\r\n\r\n